| Haemodynamic effects of inhibition of nitric oxide synthase and of L-arginine at rest and during exercise. | |
| | |
MedLine Citation:
|
PMID: 9797188 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To compare effects of N(G)-monomethyl-L-arginine (L-NMMA; a NO synthase inhibitor) and L-arginine (a NO synthase substrate) on haemodynamics in healthy men at rest and during exercise. METHODS: We infused L-NMMA and saline placebo intravenously in two groups of eight healthy men. Each group underwent a two-phase, randomized, single-blind crossover study. Men in one group received 3 mg/kg L-NMMA and men in the other group received 6 mg/kg L-NMMA. Haemodynamic measurements were performed before, during and after a 12 min stepped exercise protocol starting 6 min after the intravenous infusion. A further six men received, according to the same study design, 30 g L-arginine over 30 min and saline placebo before exercise. Blood pressure was measured by sphygmomanometry and cardiac output by bioimpedance, allowing computation of total systemic vascular resistance index (SVRI). RESULTS: Infusion of 6 mg/kg L-NMMA into men at rest produced modest increases (compared with effect of saline placebo) in systolic and diastolic blood pressures of 4.1 +/- 1.1 and 12.6 +/- 3.5%, respectively (means +/- SEM, P < 0.01 for both comparisons) and a marked increase in SVRI of 39.2 +/- 5.2% (P < 0.01). Cardiac index and heart rate were 22.0 +/- 3.3 and 17.0 +/- 4.4% lower after administration of L-NMMA (P < 0.01 for each comparison) than after infusion of saline placebo. During exercise there was no significant difference between total SVRI after infusions of L-NMMA and saline (difference not significant, diminished with increasing exercise). Six minutes into recovery the difference between total SVRI after infusions of L-NMMA and saline reappeared with SVRI 25 +/- 6.9% higher after infusion of L-NMMA than after infusion of saline (P < 0.01). Administration of L-arginine had no significant effect on haemodynamics in men at rest, during exercise and during recovery. CONCLUSIONS: Effects of L-NMMA on total systemic vascular resistance during exercise are less marked than are those on subjects at rest, probably because vasodilatation of resistance vessels of skeletal muscle during exercise is mediated mainly by factors other than NO. Our results also suggest that NO synthesis in healthy men is not substrate limited either at rest or during exercise. |
| | |
Authors:
|
S E Brett; J R Cockcroft; T G Mant; J M Ritter; P J Chowienczyk |
Related Documents
:
|
2444798 - Positive inotropic and vasodilating effects of amrinone and milrinone in isolated canin... 9375538 - Postural load during vdu work: a comparison between various work postures. 21545928 - Exercise training in congestive heart failure: risks and benefits. 14578368 - Immediate exercise hyperemia in humans is contraction intensity dependent: evidence for... 1590638 - The effect of arm exercise and ocular massage on postural hand tremor. 1910188 - Association between exercise and other preventive health behaviors among diabetics. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Journal of hypertension Volume: 16 ISSN: 0263-6352 ISO Abbreviation: J. Hypertens. Publication Date: 1998 Apr |
Date Detail:
|
Created Date: 1999-01-04 Completed Date: 1999-01-04 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8306882 Medline TA: J Hypertens Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 429-35 Citation Subset: IM |
Affiliation:
|
Department of Clinical Pharmacology United Medical and Dental School of Guy's and St Thomas' Hospital, London, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Arginine / antagonists & inhibitors, physiology* Blood Pressure / physiology* Enzyme Inhibitors / administration & dosage Exercise* Humans Male Middle Aged Nitric Oxide Synthase / antagonists & inhibitors, physiology* omega-N-Methylarginine / administration & dosage |
| Chemical | |
Reg. No./Substance:
|
0/Enzyme Inhibitors; 17035-90-4/omega-N-Methylarginine; 74-79-3/Arginine; EC 1.14.13.39/Nitric Oxide Synthase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Regular walking increases peak limb vasodilatory capacity of older hypertensive humans: implications...
Next Document: Molecular structure and function of rat platelet-derived growth factor beta-receptor gene promoter.